Evaluation of High-Dose Cytarabine Induction Therapy and Flow Cytometric Measurable Residual Disease Monitoring for Children with De Novo Acute Myeloid Leukemia: A Report from the JPLSG-AML-12 Trial

Autor: Tomizawa, Daisuke, Tanaka, Shiro *, Iwamoto, Shotaro *, Hiramatsu, Hidefumi, Matsubayashi, Jun *, Hasegawa, Daisuke *, Moritake, Hiroshi, Hasegawa, Daiichiro, Terui, Kiminori *, Hama, Asahito *, Tsujimoto, Shin-ichi *, Kiyokawa, Nobutaka *, Miyachi, Hayato *, Deguchi, Takao, Hashii, Yoshiko, Iijima-Yamashita, Yuka *, Taki, Tomohiko, Noguchi, Yasushi *, Koike, Kazutoshi *, Koh, Katsuyoshi *, Yuza, Yuki *, Saito, Akiko Moriya *, Horibe, Keizo *, Taga, Takashi *, Adachi, Souichi
Zdroj: In Blood 15 November 2022 140 Supplement 1:1450-1452
Databáze: ScienceDirect